Royalty Report: Agriculture, Forestry and Fishing, Drugs – Collection: 282872

$150.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 20

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 20

Primary Industries

  • Agriculture
  • Forestry and Fishing
  • Drugs
  • Agriculture Forestry & Fishing
  • Biotechnology
  • DNA
  • Technical Know How
  • Proteins
  • Crop Production
  • Genome
  • cell therapy
  • Biotechnologys
  • Animal Production
  • Vaccine
  • Antibody
  • Energy & Environment
  • Biomass
  • Software
  • Content
  • ribonucleic acid
  • Diagnostic
  • Therapeutic
  • Food

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 282872

License Grant
Licensor grants a world-wide, exclusive license under the Licensor Technology to make, have made, use, sell, offer for sale, and import Licensed Products and to provide Licensed Services, but excluding all uses of Licensed Products or Licensor Technology in the Plant Field and excluding all Plant Products, in each case solely in the Field and a world-wide, co-exclusive license under the Licensor Technology to make, have made, use, sell, offer for sale, and import Permitted Plant Products and to provide Permitted Plant Services, in each case solely in the Field.
License Property
Linensor has proprietary technology relating to, zmc finger proteins and their use to alter the genomes and/or protein expression capabilities of organisms and cells.

Active Supplied ZFN shall mean a Supplied ZFN having demonstrated ability to modify at least one allele of the applicable Target in a cell culture assay or other in vivo assay.

Licensed Product means any product the creation, development, manufacture, use, importation, sale or offer for sale of which, in the absence of the licenses granted in this Agreement, would infringe a Valid Claim or that incorporates Licensor Know-How, or any Licensed Service.

Supplied ZFN means nucleic acids encoding a single pair of zinc-finger protein nucleases directed against a Target.

ZFN Technology means technology relating to zinc finger proteins and their use to alter the genomes and/or protein expression capabilities of organisms and cells.

ZFP Product means a zinc-finger protein (including a zinc-finger transcription factor or a zinc-finger nuclease) or a nucleic acid encoding and capable of expressing such protein (for example, in a cell or tissue), and services in connection therewith.

Field of Use
Field means any use for research purposes. The Field shall exclude any Commercial Use of Licensed Products and any use of Licensed Products for human healthcare, including prophylaxis and diagnosis or animal healthcare including prophylaxis and diagnosis, collectively, the Excluded Fields.  

Plant Field means gene targeting and/or gene regulation using a ZFP Product to modify the genome of a plant cell, plant, or plant cell culture (in each case, whether constituting or derived from a vascular or non-vascular plant), or alter the nucleic acid or protein expression in a plant cell, plant, or plant cell culture. For the purpose of this Agreement, nonvascular plants shall include but not be limited to algae, moss, and fungi.

IPSCIO Record ID: 6483

License Grant
Licensor hereby grants the exclusive right to grant to Sublicensees a license (A) to use ZFP Products in the Field for the sole purpose of generating Licensed Products and (B) to use, make, offer to sell, sell, and import such Licensed Products, all pursuant to Technology Licenses.
License Property
Through the initial agreement the Licensee has access to our proprietary zinc finger DNA-binding protein (ZFP) technology and the exclusive right to use ZFP technology to modify the genomes or alter the nucleic acid or protein expression of plant cells, plants, or plant cell cultures. The Licensor has retained rights to use plants or plant-derived products to deliver ZFP transcription factors (ZFP TFsâ„¢) or zinc-finger nuclease (ZFNâ„¢) into human or animals for diagnostic, therapeutic, or prophylactic purposes.
Field of Use
The Licensee exercised its option under the Exclusive License Agreement that was Effective October 2005, to obtain a commercial License to sell products incorporating, or derived from, plant cells generated using the Licensor's ZFP technology, including agricultural crops, industrial products and plant-derived biopharmaceuticals. The research program has been extended beyond the initial three-year research term and the Licensee is providing additional research funding.

Field means gene targeting and/or gene regulation using a ZFP Product to modify the genome of a plant cell, plant, or plant cell culture (in each case, whether constituting or derived from a vascular or non-vascular plant), or alter the nucleic acid or protein expression in a plant cell, plant, or plant cell culture.

IPSCIO Record ID: 291180

License Grant
Licensor grants to Licensee an exclusive license in the Field and in the Territory to practice and use the Licensor Technology and to develop, make, have made, use, sell, offer to sell, and import Licensed Products.
License Property
Licensor Technology means Licensor Patents, Licensor Confidential Information, Licensor Developments, and Licensor know-how, materials, information and methods (whether developed by or on behalf of Licensor or acquired from a Third Party), including, but not limited to methods for controlling plant senescence involving altering the expression of plant genes and their cognate expressed proteins that are induced during or coincident with the onset of senescence.

Licensed Product means any product containing Licensor Technology within the Field.

Licensor Patents means (i) all U.S. and foreign patent applications owned or controlled by or licensed to Licensor or its Affiliates, pending as of the Effective Date or at any time thereafter during the term hereof, pertaining to controlling senescence, including original applications, provisionals, divisions, continuations, continuations in part, extensions, PCT applications, renewals, reissues, or reexamination applications or supplemental prosecution certificates, including, but not limited to, all applications listed; (ii) all U.S. and foreign patents that have issued or will issue from any application identified hereof; and (iii) all U.S. and foreign applications that claim priority in any way from any application or patent identified in (i) or (ii).
6,538,182 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
7,033,833 – Polynucleotides encoding carnation senescense-induced EIF-5A
6,900,368 – Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants

Field of Use
Field means all trees cultivated, harvested, or produced for any purpose (other than those grown for the purpose of edible fruit and nut production), including all derivative products resulting from such trees regardless of end use, whether transgenic or otherwise.

IPSCIO Record ID: 203521

License Grant
Licensor grants an exclusive license in the  Field under the Licensor Technology  and the Licensor Developments to develop, make, have made, use, sell, offer to sell, and import Licensed Products in the Territory.
License Property
The development and license agreement relates to Licensor's proprietary Factor 5A and DHS technology into a variety of garden plants, bedding plants and turfgrasses.

Licensor owns and controls technology,  know-how, and United States and foreign patent applications concerning methods for controlling plant senescence, cell division,  reactions to biotic or abiotic stress,  and/or plant growth by altering the expression of plant genes and their cognate expressed proteins that are induced during or coincident with the onset of senescence and/or growth.

The Patents include for the Lipase family Title: Plant lipase gene, senescence induced expression and a method for controlling senescence; and for the eIF-SA Family Title: DNA encoding a plant OHS, transgenic plants and a method for controlling programmed cell death in plants.

Licensed Product means any product developed pursuant to this Agreement which contains or is derived from an Licensor Patent and/or Technology and would infringe upon the rights granted or to be granted under the Licensor Patents.

Licensor Patents means all Licensor patents pertaining to senescence, cell division, reactions to biotic or abiotic stress, and/or growth in plants,  pertaining to senescence, cell division, reactions to biotic or abiotic stress, and/or growth in plants.

Licensor Technology means the Licensor Patents and Confidential Information, and all of Licensors know-how, materials, information and methods, whether developed by Licensor or acquired from a Third Party, including but not limited to, methods for controlling plant senescence cell division, biotic stress, abiotic stress and/or plant growth involving altering the expression of plant genes and their cognate expressed proteins that are induced during or coincident with the onset of senescence and/or plant growth.

Field of Use
The Field means the market categories for: Garden Plants including Bedding plants are flowering plants used in outdoor garden, container and hanging basket settings, Potted Plants which are herbaceous or woody flowering plants used in indoor pot situations for aesthetic purposes, Turf grass, including Fine Turf, Amenity turf grass and Recreational Turf.

The technology holds wonderful potential to enhance the performance and environmental contributions of turfgrass and ornamentals.

Licensee may also use it in turfgrasses to make them more environmentally friendly by increasing disease resistance, drought tolerance, and nutrient use efficiency.

IPSCIO Record ID: 204831

License Grant
Licensor grants
– a worldwide, exclusive license to make, have made, use and sell Commodity Oilseed Products using Licensor’s Patent Rights, with rights to sublicense;
– a worldwide, non-exclusive royalty bearing license to make, have made, use and sell any Commodity Canela Products and subject to Licensor obtaining a third party permission, Commodity High Stearate Canola Products, so long as the products do not express herbicide resistance genes using Licensor’s Patent Rights, with rights to sublicense;
– a worldwide, co-exclusive with Licensor’s license to make, have made, use and sell Commodity Canola Products and subject to the third party written permission, Commodity High Stearate Canola Products, so long as the products express herbicide resistance genes, using Licensor’s Patent Rights,  and
– a worldwide, non-exclusive license, with no right to sublicense, to make, have made and use, for research purposes only, oilseed products other than Commodity Oilseed Products, Commodity Canola Products and Commodity High Stearate Canola Products using Licensor’s Patent Rights.
License Property
Licensor has certain technology useful in manipulating seed oil composition, and other technology applicable to the expression of traits in plants which can be used to express genes for oil modification,  meal modification or the  introduction of useful agronomic traits into oilseed crops.

Agronomic Genes shall mean genes encoding for disease resistance, herbicide tolerance, cold tolerance, shatter resistance, yield improvement,  earliness,  insect  tolerance,  drought  resistance  and heat resistance and other genes that reduce the net unit cost of production of agricultural crop plants.

The patents relate to Method & Compositions for Introducing Alien DNA in Vitro.

Field of Use
This agreement is for the agriculture production industry.

IPSCIO Record ID: 204996

License Grant
For Research use, Licensor grants a non-exclusive, nontransferable, nonsublicensable, worldwide license under Licensor s interest in the Intellectual Property and Materials, and a non-exclusive, nontransferable, non-sublicensable, worldwide license under any patents, trade secrets and other intellectual property owned or Controlled by Licensor that are necessary or useful for the conduct of the R&D Program.

For Commercial use, Licensor agrees to grant, and hereby grants, a worldwide, royalty-bearing license under Licensors interest in the Intellectual Property, as follows:
– an exclusive license to make, have made, and use Shuffled Genes, excluding any Licensor SGD, and Enabling Technology together with Shuffled Genes, excluding any Licensor SGD, in each case, in Licensees Crops, to develop, make, have made, propagate, have propagated, use, import, offer for sale, sell and have sold Licensee Licensed Products, including the right to grant sublicenses ; and
– a non-exclusive license to make, have made, and use Research Results subject to and in Licensee Crops, to develop, make, have made, use, import, offer for sale, sell and have sold Licensee Licensed Products, including the right to grant sublicenses.

Licensor grants, a worldwide, license under Licensors interest in the Intellectual Property as follows :
– an exclusive license to make, have made, sell, offer to sell, import and use Shuffled Genes, excluding Licensor SGDs, in Plants other than Licensor Crops and Licensee Crops, and for uses other than in Plants, and to develop, make, have made, use, import, offer for sale, sell and have sold Licensee Licensed Products derived therefrom, including the right to grant sublicenses; and
– a non-exclusive license to make, have made, sell, offer to sell, import and use Research Results subject to and in Plants other than Licensor Crops and Licensee Crops, and for uses other than in Plants, and to develop, make, have made, use, import, offer for sale, sell and have sold Licensee Licensed Products derived therefrom, including the right to grant sublicenses.

License Property
Licensor has expertise in the breeding and development of proprietary crop species.
Field of Use
Licensee has expertise in the rearrangement of DNA to produce and discover genes utilizing proprietary technologies.  This agreement is to produce improved seeds and agricultural products,

IPSCIO Record ID: 240464

License Grant
Licensor agrees to grant, and hereby grants to the United Kingdom Licensee a non-exclusive, non-transferable and non-sublicensable (other than to Licensee Affiliates and Third Parties as agreed by the Research Committee), royalty-free, worldwide license under Licensors interest in the Program Technology,  Licensor Materials and Licensor Improvements, solely to conduct the Research Program.

Licensor agrees to grant, and hereby grants, to Licensee, a worldwide, royalty-bearing license, with the right to sublicense, under Licensors interest in the Program Technology (whether solely or jointly owned by Licensor), Licensor Improvements and the Licensor Materials, as follows:
(a) an exclusive license to develop, make, have made, propagate and have propagated, use, import, offer for sale, sell and have sold Class A Licensee Products for Agricultural Applications in Plants and Class B Licensee Products for Agricultural Applications in Crops; and
(b) an exclusive license to develop, make, have made, propagate and have propagated, use, import, offer for sale, sell and have sold Class A Licensee Products for Non-Ag Applications.

License Property
Program Technology means all Program Patent Rights, Know-How and Program Materials, in each case, which is necessary or useful for the development, testing, use, manufacture or sale of Licensee Products or Licensor Products. It is understood that the Program Technology does not include any Shuffling Technology or Licensee Proprietary Technology.

Licensee Product means any product sold or intended to be sold by Licensee or its Affiliates or Sublicensees which incorporates or is made through the use of a Shuffled Gene, or is derived from a Plant which incorporates or is made through the use of a Shuffled Gene.

Class A Licensee Product means a product commercialized by Licensee or its Affiliates or Sublicensees which incorporates or is made through the use of one or more Class A Shuffled Genes.

Class B Licensee Product means a product commercialized by Licensee or Affiliates or Sublicensees which incorporates or is made through the use of at least one Shuffled Gene, but which does not incorporate and is not made through the use of any Class A Shuffled Gene.

Licensor Materials means all Materials provided by Licensor to Licensee in order that Licensee can perform its obligations under the Research Program or which Licensor owns and Controls and uses internally in connection with the Research Program. It is understood and agreed that all Nucleic Acid Sequence Libraries, Gene Variants and Shuffled Genes shall be Licensor Materials.

Licensor Product means any product sold by Licensor or its Affiliates or Sublicensees which incorporates or is made through the use of a Class B Shuffled Gene, or is derived from a Plant which incorporates or is made through the use of a Class B Shuffled Gene.

Class A Shuffled Gene means any Shuffled Gene which results is or derived from the Shuffling in the Research Program of [ at least one Licensee Starting Gene, whether or not Shuffled with another Licensee Starting Gene, an Other Starting Gene and/or a Licensor Starting Gene.

Class B Shuffled Gene means a Shuffled Gene that is not a Class A Shuffled Gene.

Gene means a polynucleotide sequence encoding a protein, optionally together with its regulatory sequences, which is selected for Shuffling in the Research Program by the Research Committee.  Each Gene shall be designated by the Research Committee as (i) a Licensee Starting Gene or (ii) a Licensor Starting Gene or (iii) an Other Starting Gene.

Field of Use
This agreement pertains to the Agricultural industry.

IPSCIO Record ID: 209554

License Grant
Licensor grants under the Licensed Patent Rights and Fatty Acid Metabolism Know How and during the term, a non-exclusive, world-wide sublicense to make and use Licensed Products and the right to sell or sublicense others to sell Licensees Oilseed Crop Plants.
License Property
Licensed products means genes, vectors, plant cells, plants and seed thereof of plants containing a gene which encodes for the sense or antisense of an enzyme in the fatty acid metabolism pathway.
Field of Use
The field means the area of plant oil modification through genetic engineering to produce specialty oil products.

IPSCIO Record ID: 6518

License Grant
The Licensor amended its License Agreement with the Licensee to expand the exclusive License to the zinc finger DNA-binding protein (“ZFP”) technology. Under the original License Agreement, the Licensor agreed to provide the Licensee with the exclusive right to use the ZFP technology to develop and commercialize products for research use and to offer services in the research field, excluding certain agricultural research uses that the Licensor previously Licensed to Dow AgroSciences LLC.

Pursuant to this amendment, the Licensor granted the Licensee an additional License for certain commercial uses of products and services arising from the ZFP technology, including the use of ZFPs to modify cell lines for GMP production purposes and certain commercial uses of ZFP-modified transgenic animals. The foregoing License is exclusive, except for commercial rights to the ZFP technology previously granted to various third parties in some of the fields being Licensed to the Licensee. The Licensor retained all rights to ZFP-modified transgenic animals for discovery of novel therapeutic entities, and the additional License granted to Sigma does not include any right to use ZFPs as therapeutic products. Sigma has the right to sublicense the ZFP technology for the commercial uses of products and services covered by the Amendment.

License Property
ZFP is a proprietary zinc finger DNA-binding protein.  Zinc finger proteins are among the most abundant proteins in eukaryotic genomes.

“GMP Product” means a Licensed Product that (a) is a eukaryotic cell or eukaryotic cell line, the genome or genetic composition of which has been modified through the use (whether directly or indirectly) of a ZFP Product in a manner that (i) facilitates or improves the ability of such cell or cell line to produce a Therapeutic Product or (ii) modifies the molecular characteristics of such Therapeutic Product and (b) is not a Plant Product.”

“Livestock Product” means a Licensed Product that is a livestock animal (including, but not limited to fish), the genome or genetic composition of which has been modified through the use (whether directly or indirectly) of a ZFP Product in a manner that improves the quality, quantity or characteristics of a human or animal food or other naturally occurring products (e.g., wool, leather) made by or derived from such animal, provided that such food or naturally occurring product is not a Therapeutic Product or a ZFP Therapeutic Product.”

Field of Use
“Livestock Field” means use of a Livestock Product for the production of human food or another naturally occurring product.”

IPSCIO Record ID: 204997

License Grant
Licensor grants
– a worldwide, exclusive, to the extent such exclusivity is possible in the light of  existing agreements, license to make, have made, use and sell Specialty Canola Products and Specialty High Stearate Canola Products using Licensor Patent Rights, with rights to sublicense,
– a worldwide, non-exclusive license to make, have made, use and sell Commodity Canola Products and Commodity High Stearate Canola Products using Licensor Patent Rights, without the right to sublicense
– a worldwide, non-exclusive license, with no right to sublicense, to make, have made and use, for research purposes only, oilseed products other than Commodity Canola Products, Commodity High Stearate Canola Products, Specialty Canola Products and Specialty High Stearate Canola Products using Licensor Patent Rights, and  
– for Specialty Canola Products and Specialty High Stearate Canola Products, the limited right to sublicense only transgenic plant germplasm produced by Licensee, with the right to develop, use and sell new varieties and/or hybrids produced therefrom by traditional plant breeding, containing genes developed or in-licensed by Licensee to any Third Party or Licensee Affiliate.
License Property
Licensor has proprietary rights to certain technology applicable to the engineering of plants and in plant expression, as well as technology for introducing agronomic traits, which is useful in the improvement of oilseeds and in modifying oil composition.

Agronomic Genes shall mean genes encoding for disease resistance, herbicide tolerance, cold tolerance, shatter resistance, yield improvement,  earliness,  insect  tolerance,  drought  resistance  and heat resistance and other genes that reduce the net unit cost of production of agricultural crop plants.

The patents relate to Increased starch content in Plants and Expression of Sucrose Phosphorylase in Plants.

Field of Use
This agreement is for the agriculture production industry.

IPSCIO Record ID: 56588

License Grant
In this related party agreement, the Licensor hereby grants to Licensee a nonexclusive license in the Territory, with the right to sublicense, to use iBioLaunchâ„¢ Technology and iBio Additional Technology to conduct Process Development, Scale-Up, and R&D activities on Pharmaceutical Products in the Territory. Additionally, subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee a nonexclusive license in the Territory, with the right to sublicense, to use the iBio Additional Technology to conduct Process Development, Scale-Up, and R&D activities on Products in the Territory.
License Property
The patents and technology are for the accelerated discovery and production of improved vaccines, monoclonal antibodies, therapeutic proteins, and other products derived from green plants utilizing its iBioLaunchâ„¢ plant-based platform technology and other proprietary technologies.

7,012,172   VIRUS INDUCED GENE SILENCING IN PLANTS   3/14/2006
          
7,491,509   SYSTEM FOR EXPRESSION OF GENES IN PLANTS   2/17/2009
          
7,683,238   PRODUCTION OF PHARMACEUTICALLY ACTIVE PROTEINS IN SPROUTED SEEDLINGS   3/23/2010
          
7,692,063   PRODUCTION OF FOREIGN NUCLEIC ACIDS AND POLYPEPTIDES IN SPROUT SYSTEMS   4/6/2010
          
8,058,511   SYSTEM FOR EXPRESSION OF GENES IN PLANTS   11/15/2011
          
8,148,608   SYSTEMS AND METHODS FOR CLONAL EXPRESSION IN PLANTS   4/3/2012
          
8,173,408   RECOMBINANT CARRIER MOLECULE FOR EXPRESSION, DELIVERY AND PURIFICATION OF TARGET POLYPEPTIDES   5/8/2012
          
8,591,909   RECOMBINANT CARRIER MOLECULE FOR EXPRESSION, DELIVERY AND PURIFICATION OF TARGET POLYPEPTIDES   11/26/2013
          
8,597,942   SYSTEM FOR EXPRESSION OF GENES IN PLANTS   12/3/2013
          
8,951,791   SYSTEM FOR EXPRESSION OF GENES IN PLANTS   2/10/2015
          
9,012,199   RECOMBINANT CARRIER MOLECULE FOR EXPRESSION, DELIVERY AND PURIFICATION OF TARGET POLYPEPTIDES   4/21/2015

Field of Use
This agreement pertains to the patents and technologies for research, process development and scale-up, and manufacturing of plant-derived products in a manufacturing facility designed for that purpose relating to drugs in the healthcare industry.

IPSCIO Record ID: 291128

License Grant
The Licensor Parties and their Affiliates grant to Licensee, and Licensee accepts, an exclusive, royalty-free, sublicensable license under and to use the Biofuel IP to perform research and development activities with respect to Licensed Products in the Field and in the Territory to evaluate the Licensee in order to determine Licensor’s interest in obtaining the Commercialization License (the Evaluation License).

The Licensor Parties and their Affiliates grant to Licensee, and Licensee accepts, an exclusive, royalty-bearing, sublicensable  license under and to use the Biofuel IP to research, develop, make, have made, use, import, export, offer to sell and sell Licensed Products in the Field and in the Territory (the Commercialization License).

License Property
Biofuel IP means (a) the Biofuel Patent Rights; and (b) the Biofuel Know-How.

Biofuel Patent Rights means (a) the Existing Biofuel Patent Rights, (b) any and all Patent Rights that claim Biofuel Know-How and that are Controlled by the Licensor Parties or their Affiliates as of the Effective Date and/or during the Term, including the Licensor Parties’ and their Affiliates’ interest in any Joint Patent, and (c) Licensor Improvement Patent Rights.

7,087,419 – DNA encoding a plant lipase, transgenic plants and a method for controlling senescence in plants
6,538,182 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
6,989,258 – DNA encoding a plant deoxyhpusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants

Licensed Products means any product in the Field that incorporates, contains, utilizes, is enabled by or otherwise exploits the Biofuel IP, or the making, using, selling or importing of which would, absent the Licenses granted hereunder, infringe the Biofuel IP.

Licensor Improvement Patent Rights means any and all Patent Rights that claim Technology created by or on behalf of a Licensor Party or its Affiliates in the course of performing research or development outside of the Field during the Term and which Technology (i) is an improvement to the Existing Technology or any Developed Technology, and (ii) is applicable to plants and plant products (including plant organisms, progeny, cells, seeds, grain, grain component, tissue, and other parts of plants, but excluding Excluded Products).

Technology means all ideas, inventions, discoveries, biologic and other materials, trade secrets, data, instructions, formulae, designs, specifications, methods, processes, formulations, assays, techniques, know-how, technical information (including structural and functional information), and manufacturing process information, patentable or otherwise.

Developed Technology means any and all Technology that is (a) created by or on behalf of the Licensor Parties or their Affiliates in the course of performing research or development in the Field during the Term, or (b) created pursuant to the Services provided by the Licensor Parties’ or their Affiliates’ employees pursuant to this Agreement  (excluding Licensee Owned Service Improvements), in each case that is Controlled by a Licensor Party or its Affiliates during the Term.

Field of Use
Research and development agreement is to use Licensor's proprietary eukaryotic translation initiation Factor 5A (eIF5A) technology platform for sustainable energy applications Licensee, a newly formed start-up company, will have a license to evaluate our technology for the development of plants and plant products suitable for use in the production of biofuel and biofuel feedstock, including all species of algae and all species in the genus Miscanthus (perennial grasses). Biofuels derived from these organisms include biodiesel and bioethanol.

Field means any and all (a) plants and plant products (including plant organisms, progeny, cells, seeds, grain, grain component, tissue, and other parts of plants) suitable for use in the production of biofuel and/or biofuel feedstock, including all species of algae and all species in the genus Miscanthus, but excluding the Excluded Products; (b) biodiesel, bioethanol and other biofuels derived from the plants and plant products described in clause (a) above; and (c) other products derived from the plants and plant products described in clause (a), other than pharmaceutical, nutraceutical and food products, provided that the foregoing exclusion of food products shall not apply to algae.

IPSCIO Record ID: 290208

License Grant
Licensor hereby grants Netherlands Licensee and its Affiliates a non-exclusive, worldwide, non-terminable license with the right to grant sublicenses, under the Licensor Patent Rights (other than the Licensor Antibody Patent Rights), for all uses in the Field, including, without limitation, to make, have made, use, sell, offer for sale, import and export Licensee Licensed Products in the Field. Such license shall not expire until the earlier of (i) the expiration of the last to expire Valid Claim of the Licensor Patent Rights other than the Licensor Antibody Patent Rights or (ii) termination of this Agreement of this Agreement.
License Property
Licensee Licensed Product shall mean any product, the manufacture, use, or sale of which would, absent the licenses granted to Licensee hereunder, infringe one or more Valid Claims of the Licensor Patent Rights.

Licensor Patent Rights shall mean: (a) USSN 07/938,322 entitled 'Transgenic Animals Secreting Desired Proteins into Milk', including, without limitation, EP-973031124, and any foreign counterpart applications, together with any and all patents that have issued or in the case of applications heretofore filed, in the future issue therefrom or whose priority date is based thereon; and (b) all related divisionals,  continuations, national stage applications or patents filed under the Patent Cooperation Treaty of 1978, reissues or renewals, of the foregoing; and (c) the Licensor Antibody Patent Rights.

Licensor Antibody Patent Rights shall mean (a) U.S. Patent Nos. 5,827,690 and 5,849,992 both entitled 'Transgenic Production of Antibodies in Milk', and all U.S. patent applications and any foreign counterpart applications, and future issued patents including all patents that have issued or in the case of applications heretofore filed, in the future issue therefrom or whose priority date is based thereon; and all related divisionals, continuations, national stage applications or patents filed under the Patent Cooperation Treaty of 1978, reissues or renewals, of the foregoing pertaining to the production of antibodies in the milk of transgenic mammals.

Biopharmaceutical shall mean any medicinal drug, therapeutic, vaccine or any medically useful composition whose origin, synthesis, or manufacture involves the use of microorganisms, recombinant animals (including, without limitation, chimeric or transgenic animals), nuclear transfer, microinjection, or cell culture techniques.

HSA shall mean human serum albumin.

Field of Use
This agreement pertains to the agricultural Industry.

Field shall mean: (a) the Cattle Field; (b) the Goat Field; (c) the production, use and/or sale of transgenic or chimeric mice, rabbits, pigs, and/or sheep (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric animals; and (d) the use in any transgenic or chimeric cattle, goats, mice, rabbits, pigs, and/or sheep of a nucleic acid construct useful in the production of a system that includes the use of a recombinant casein promoter sequence, which permits a female transgenic or chimeric animal to produce a desired Biopharmaceutical in the milk (or any fraction thereof) of such a transgenic or chimeric cattle, goats, mice, rabbits, pigs, and/or sheep
during lactation.

Goat Field shall mean the production, use and/or sale of transgenic or chimeric goats (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction
thereof) secreted from such transgenic or chimeric goats.

Cattle Field shall mean the production, use and/or sale of transgenic or chimeric cattle (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric cattle, including, without limitation, the production of hSA.

IPSCIO Record ID: 27201

License Grant
The Company hereby grants under the Licensed Patent Rights a non-exclusive, royalty-bearing, world-wide license to make and use Licensed Products in the Field and the right to sell or sublicense others to sell Produce Plants.
License Property
Produce Plants shall mean fresh and processed tomatoes, berries, mangoes, cucurbits, peppers and sweetcorn.

Licensed Products shall mean genes, vectors, Produce Plant cells, Produce Plants and seed thereof of PRODUCE PLANTS containing a gene which encodes for the sense or antisense of a gene which, in the absence of a license, would infringe at least one (1) claim of an unexpired U.S. or foreign patent included within Licensed Patent Rights.

U.S. Serial No. 06/917,027 filed 10/9/86

Field of Use
Field shall mean the cucumber mosaic coat protein gene for use in Produce Plants.

IPSCIO Record ID: 203441

License Grant
Licensor agrees to assign to Licensee the Licensors right, title and interest to the Licensee DNA Information developed by Licensor and DNA Patent Rights.

Licensor grants a non-exclusive, worldwide license for internal use only,  for the Analytical Technology, developed by either party, following a material contribution to the development thereof by Licensee. This license includes Licensees right to use such Analytical Technology to develop, make, have made, import, use, sell, have sold, and offer to sell Licensed Products and in connection with a bona fide scientific collaboration between Licensee and a third party under a written contract and research plan in a specific area. This license does not include Licensees right to transfer, sell, or license such Analytical Technology.

License Property
Technology  refers to a cutting edge informational genomics technologies to the development of better crops.

Analytical Technology shall mean algorithms and other analytical techniques and methods, including, without limitation, methods of generating, storing, retrieving and analyzing data developed in the course of carrying out the Project Plan.

Analytical Patent Rights shall mean inventions related to Analytical Technology developed by or for Licensee carrying out the Project Plan expressly excluding inventions related to DNA sequences or oligonucleotide probe sequences, array designs, array data and the results of analysis of such array data.

Licensed Products shall mean a particular product or a particular species of animals, plants, plant or animal parts, animal progeny, seed of plants and products from any of the foregoing, or the process of making, modifying or modulating any of the foregoing or any phenotypic trait associated with any of the foregoing, which, in the absence of a license, would infringe at least one (1) claim of an unexpired U.S. or foreign patent or one (1) pending claim of an unexpired published patent application included within DNA Patent Rights which claims a Gene Lead.

Gene Lead shall mean any gene identified by Licensor in connection with its analysis of Licensee DNA Information and which has been determined to be a Gene Lead. Each Gene Lead shall be included in Licensee DNA Information.

Field of Use
This agreement specifically relates to maize and rice and tissue-specific oligonucleotides.

The parties research alliance is for creating proprietary intellectual property relating to the design, development and use of microarrays, the design, development and application of gene expression databases and the identification of genes predictive of traits.

IPSCIO Record ID: 266848

License Grant
For the License of Platform Technology and Biomolecules, Licensor grants the Swiss Licensee a perpetual, exclusive, worldwide license, with the right to sublicense, under the Patent Rights and Know-How Controlled by Licensor and its Affiliates to make, have made and use all of the Biomolecules that demonstrated the minimum criteria levels specified in the applicable Project Plans to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Licensee Exclusive Field.

Licensor agrees to grant to Licensee and its Affiliates a perpetual, worldwide license, with the right to sublicense, under the Patent Rights and Know-How Controlled by Licensor and its Affiliates to make, have made and use all other Biomolecules discovered or provided in the course of the Projects under the Research Program which did not demonstrate such minimum criteria levels to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Licensee Exclusive Field provided Licensor shall grant a license to such Biomolecule in the Licensee Exclusive Field to the greatest extent that Licensor has not granted such rights to a Third Party(ies).

Licensor agrees to grant a worldwide license, with the right to sublicense, to use the Platform Technology Improvements which are owned by Licensor in the Licensee Exclusive Field.

License Property
The licensed patents include, but are not limited to, Method For Identification, Separation And Quantitative Measurement Of Nucleic Acid Fragments;  System And Method For High Throughput Tissue Disruption;  System And Method For Storing Mass Spectrometry Data; and,  identification of Protein Interactions Using In Vitro Post-Translationally Modified Fusion Proteins.

Platform Technology means all tools, technologies and methods relating to proteomics, metabolomics, RNA dynamics and bioinformatics and methods to analyze and link these components of genomics, which are both not publicly available and are proprietary to or Controlled by Licensee or its Affiliates immediately prior to the closing of the transactions under the Transaction Agreement, and claimed or disclosed within the patent applications and patents or are within the scope of the material trade secrets related thereto.

Biomolecule means any Gene and RNA and protein or chemical entity the synthesis of which is directed by such Gene or Gene pathway, which protein or chemical entity was produced by an organism.

Gene means a polynucleotide sequence which can be transcribed into RNA and generally encodes a protein, optionally together with its regulatory sequences.

Plant means a monocotyledonous or dicotyledonous plant, or an angiosperm, a gymnosperm or a pteridophyte.

Field of Use
Licensee Exclusive Field means:  any Biomolecule with Plants as the expression host;  any Plant Gene; any Biomolecule for admixture to the product of any physical or chemical processing of Crops or derivatives of Crops provided that the product contains Plant material unique to Plants; any Biomolecule for any industrial application involving Crops or the close derivatives of Crops, but excluding inert or minor ingredients from or derived from a Plant source which do not materially add value to an end product of an industrial manufacturing process; any Biomolecule useful for Licensees actual or potential customers in the agriculture, food and/or natural fibers markets involving the use of Crops, or the use of close derivatives of Crops (including all uses of corn, wheat, barley, rice, cotton and soy, and other oil Crops and their close derivatives), but excluding inert or minor ingredients from or derived from a Plant source which do not materially add value to an end product of an industrial manufacturing process; any Biomolecule with commercial value, alone or In combination with other Biomolecules, for use in the Animal Feed Field; and, any Project described in the Project List and including the new protein therapeutic projects undertaken.

Animal Feed Field means the use of Biomolecules for feed applications to alter, modify or improve feed conversion and/or animal nutrition, but excluding all vaccines and therapeutic applications and any part of such field to which rights have been granted to Licensee or Licensee or any of its Affiliates under the Licensee Agreements.

IPSCIO Record ID: 223436

License Grant
Licensor agrees to assign to Licensee the Licensors right, title and interest to the Licensee DNA Information developed by Licensor and DNA Patent Rights.

Licensor grants a non-exclusive, worldwide license for internal use only,  for the Analytical Technology, developed by either party, following a material contribution to the development thereof by Licensee. This license includes Licensees right to use such Analytical Technology to develop, make, have made, import, use, sell, have sold, and offer to sell Licensed Products and in connection with a bona fide scientific collaboration between Licensee and a third party under a written contract and research plan in a specific area. This license does not include Licensees right to transfer, sell, or license such Analytical Technology.

License Property
Analytical Technology shall mean algorithms and other analytical techniques and methods, including, without limitation, methods of generating, storing, retrieving and analyzing data developed in the course of carrying out the Project Plan.

Analytical Patent Rights shall mean inventions related to Analytical Technology developed by or for Licensee carrying out the Project Plan expressly excluding inventions related to DNA sequences or oligonucleotide probe sequences, array designs, array data and the results of analysis of such array data.

Licensed Products shall mean a particular product or a particular species of animals, plants, plant or animal parts, animal progeny, seed of plants and products from any of the foregoing, or the process of making, modifying or modulating any of the foregoing or any phenotypic trait associated with any of the foregoing, which, in the absence of a license, would infringe at least one (1) claim of an unexpired U.S. or foreign patent or one (1) pending claim of an unexpired published patent application included within DNA Patent Rights which claims a Gene Lead.

Predictive Pattern Technology shall mean a particular product, not including plant or animal, plant or animal parts, animal progeny, used to predict characteristics.

DNA Patent Rights shall mean inventions utilizing Licensee DNA Information developed by or for Licensor in the course of carrying out the Project Plan.

Gene Lead shall mean any gene identified by Licensor in connection with its analysis of Licensee DNA Information and which has been determined to be a Gene Lead. Each Gene Lead shall be included in Licensee DNA Information.

This agreement specifically relates to maize and rice and tissue-specific oligonucleotides.

Field of Use
The parties research alliance is for creating proprietary intellectual property relating to the design, development and use of microarrays, the design, development and application of gene expression databases and the identification of genes predictive of traits.

IPSCIO Record ID: 256191

License Grant
The University grants the sole and exclusive right and license to make, use, offer to sell, sell, import and sublicense Licensed Patents within the Field of Use and in the Licensed Territory for the Term.
License Property
The patents include, but are not limited to:
—  Production of Transgenic Early Embryonic Chicken Cells and Chimeric Chickens Using EGFP and Puromycin Selection Methods,
—  Transgenesis of Early Embryonic Cells,
—  Avians that Produce Eggs Containing Exogenous Proteins,
—  Exogenous Proteins Expressed in Avians and Their Eggs,
—  Novel Vectors in Avian Transgenesis,
—  Vectors Comprising a Magnum-Specific Promoter for Avian Transgenesis, and,
—  Method for Manipulating Eggs
Field of Use
The Field of Use means avian trans genesis as it may relate to introduction of DNA sequences in any avian species expression of autologous and allogeneic molecules in any avian species, use of avians and their eggs as bioreactor] and improved poultry production genetics.

IPSCIO Record ID: 6615

License Grant
The Licensor entered into a research and License Agreement with the Licensee pursuant to which the Licensor provided access to aspects of their proprietary ZFN technology. During an initial research term, the Licensee had the right to use ZFNs provided by Licensor to generate ZFN-modified cell lines and animals having targeted modifications in a specified gene in a specified species, solely for research purposes. In December 2009, pursuant to the research and License Agreement the Licensee exercised an option to receive an exclusive, worldwide License to use such animals in the production of therapeutic and diagnostic products. The Licensor has agreed not to transfer or License to third parties the specific ZFNs provided to the Licensee under the research and License Agreement, or derivatives of such ZFNs.
License Property
ZFP's are a zinc finger DNA-binding proteins, a naturally occurring class of proteins. The Licensor has used knowledge and expertise to develop a proprietary technology platform. ZFPs can be engineered to make ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off, and ZFP nucleases (ZFNs), proteins that enable us to modify DNA sequences in a variety of ways. As ZFPs act at the DNA level, they have broad potential applications in several areas including human therapeutics, plant agriculture, research reagents, transgenic animal and cell-line engineering.
Field of Use
The rights granted apply to research purposes.

IPSCIO Record ID: 197618

License Grant
The French Licensor grants the Licensee, a subsidiary, an exclusive (except as otherwise provided) worldwide, perpetual license, with the right to sublicense under the Licensed IP to use, have used, make, have made, sell, have sold, offer for sale, export, import and otherwise exploit any and all Licensee Licensed Products within the Licensee Field of commercialization of agricultural and food products.
License Property
The Licensee's TALEN technology uses 'molecular scissors' to create desirable traits and does not add foreign DNA during the process.

Licensed TALEN Mark

Field of Use
The TALEN method produces plants regarded as non-GMO. That’s because unlike controversial GMO foods, there is no introduction of foreign DNA into the plant genome, such as is done to enhance the ability to crops to resist pesticides. Instead, the TALEN process is used only to strategically deactivate genes to achieve desired traits, such as to produce less fat in a soybean, and thus is seen as essentially no different from naturally occurring mutations.

The Licensee's aims to make genetically modified crops for consumers and farmers using technology developed at a French gene-editing

The Licensee is in the field of researching, developing and commercializing agricultural and food products, including, but not limited to traits, seeds, proteins, oils, carbohydrates, food, and food and animal feed ingredients, excluding any application in connection with animals and animal cells.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.